ストックスクリーナーアプリを入手
60.37
1.95%
-1.20
アフターアワーズ：
60.30
-0.07
-0.12%
Cg Oncology Inc (CGON) 最新ニュース
Rafferty Asset Management LLC Lowers Stock Position in CG Oncology, Inc. $CGON - MarketBeat
Tech Rally: Will CG Oncology Inc stock recover after earningsInsider Buying & Risk Managed Investment Strategies - baoquankhu1.vn
Stock Traders Buy High Volume of Call Options on CG Oncology (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. $CGON Stock Holdings Trimmed by TD Asset Management Inc - MarketBeat
Lifesci Capital Predicts Stronger Earnings for CG Oncology - MarketBeat
CG Oncology (NASDAQ:CGON) Sets New 12-Month HighTime to Buy? - MarketBeat
CG Oncology, Inc. (CGON) Stock Analysis: A 39% Potential Upside in the Battle Against Bladder Cancer - DirectorsTalk Interviews
CG Oncology stock hits all-time high at 60.01 USD By Investing.com - Investing.com Australia
CG Oncology stock hits all-time high at 60.01 USD - Investing.com
CG Oncology (CGON) Valuation Check As Bladder Cancer Trial Timelines Accelerate And Cash Runway Extends To 2029 - Sahm
NMIBC Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Ferring Pharmaceuticals, FKD Therapies Oy, ImmunityBio, CG Oncology, Pfizer, UroGen Pharma, Janssen R&D - StreetInsider
CGON Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Buy Rating on CG Oncology Driven by PIVOT-006 Differentiation and 2026 Clinical, Regulatory Catalysts Supporting Favorable Risk–Reward - TipRanks
CGON: Credo shows high efficacy and durability, with regulatory and commercial plans advancing - TradingView
H.C. Wainwright raises CG Oncology stock price target to $80 By Investing.com - Investing.com Canada
H.C. Wainwright raises CG Oncology stock price target to $80 - Investing.com
AI Stocks: What is the dividend yield of CG Oncology IncJuly 2025 PostEarnings & Verified Swing Trading Watchlists - baoquankhu1.vn
Vanguard Group Inc. Has $264.93 Million Stock Position in CG Oncology, Inc. $CGON - MarketBeat
The Bull Case For CG Oncology (CGON) Could Change Following Surging Revenue And Deeper 2025 Losses – Learn Why - simplywall.st
What Analysts Are Saying About CG Oncology Stock - Benzinga
HC Wainwright Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price - MarketBeat
CGON Stock: HC Wainwright & Co. Maintains Rating, Raises Price T - GuruFocus
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale - AOL.com
Why CG Oncology Stock Is Suddenly Surging Higher - TipRanks
CG Oncology (NASDAQ:CGON) Trading Up 5.6% Following Strong Earnings - MarketBeat
CG Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
CG Oncology Q4 Net Loss Widens; Expects Cash Runway Into 2029 - marketscreener.com
CG Oncology, Inc. SEC 10-K Report - TradingView
CGON: Net loss rose to $161M as R&D and G&A costs increased; $742M cash on hand funds 12+ months - TradingView
CG Oncology (CGON) builds late-stage bladder cancer franchise on cretostimogene - Stock Titan
CGON: 2025 net loss widened to $161M as R&D ramped up, with $903M cash to fund operations into 2029 - TradingView
CG Oncology (NASDAQ: CGON) widens 2025 loss but secures $903M cash and nears Phase 3 data - Stock Titan
CG Oncology Reports Strong Cash Position and Upcoming Milestones for Cretostimogene Development in NMIBC Trials - Quiver Quantitative
Earnings Flash (CGON) CG Oncology Posts 2025 Total Revenue $4M, vs. FactSet Est of $2.8M - marketscreener.com
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates - The Manila Times
CG Oncology lines up 2026 NMIBC trial readouts with $903M cash - Stock Titan
CG Oncology Q4 Earnings Report: What Investors Need to Know - Sahm
According to the latest financial data from CG Oncology Inc., the company currently holds a total of $903 millions in cash, cash equivalents, and marketable securities. - Bitget
CG Oncology, Inc. unveils five cretostimogene research posters at ASCO GU in San Francisco - Traders Union
CG Oncology (NASDAQ:CGON) Sets New 52-Week HighTime to Buy? - MarketBeat
CG Oncology, Inc. (CGON) Stock Analysis: Unveiling a Potential 36.95% Upside in the Biotech Sector - DirectorsTalk Interviews
JP Morgan Initiates Coverage of CG Oncology (CGON) with Overweight Recommendation - MSN
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference - The Manila Times
CG Oncology leaders at TD Cowen health conference, webcast March 2 - Stock Titan
Assessing CG Oncology (CGON) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
CG Oncology stock hits all-time high at 57.92 USD By Investing.com - Investing.com India
Analysts Are Bullish on These Healthcare Stocks: CG Oncology, Inc. (CGON), Qiagen (QGEN) - The Globe and Mail
CG Oncology (NASDAQ:CGON) Hits New 12-Month HighHere's Why - MarketBeat
What are CG Oncology Inc.’s technical support levels2025 Volume Leaders & High Accuracy Investment Signals - mfd.ru
CG Oncology stock hits all-time high at 57.92 USD - Investing.com South Africa
Muscle Invasive Bladder Cancer Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | CG Oncology, Pfizer, UroGen Pharma, Janssen R&D, Protara Therapeutics, Binhui Biopharmaceutical - Barchart.com
CenterBook Partners LP Has $15.92 Million Stake in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology, Inc. (CGON) Stock Analysis: A 55% Upside Potential In The Biotech Sector - DirectorsTalk Interviews
Analyst Downgrade: What is the PEG ratio of EUDAWMarket Trend Review & Technical Pattern Recognition Alerts - baoquankhu1.vn
Did Faster PIVOT-006 Readout and Enlarged ATM Offering Just Shift CG Oncology's (CGON) Investment Narrative? - Sahm
CG Oncology's Creto Launch Could See Headwind From Reimbursement Incentives, RBC Says - marketscreener.com
Will CG Oncology Inc. stock hit new highs in YEARWeekly Volume Report & Free Risk Controlled Daily Trade Plans - mfd.ru
Why CG Oncology Inc. stock remains on buy listsDay Trade & Free Growth Oriented Trading Recommendations - mfd.ru
CG Oncology stock price target raised to $75 from $66 at Truist Securities - Investing.com Nigeria
CG Oncology stock price target raised to $75 from $66 at Truist Securities By Investing.com - Investing.com South Africa
Truist Financial Boosts CG Oncology (NASDAQ:CGON) Price Target to $75.00 - MarketBeat
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):